-
Vosoritide, sold
under the
brand name Voxzogo, is a
medication used for the
treatment of achondroplasia. The most
common side
effects include injection...
-
Treatments include small molecule therapy with a C-natriuretic
peptide analog (
vosoritide),
approved to
improve growth velocity in
children with achondroplasia...
-
ranelate M05BX04
Denosumab M05BX05
Burosumab M05BX06
Romosozumab M05BX07
Vosoritide M05BX08
Menatetrenone M05BX53
Strontium ranelate and
colecalciferol "ATC...
-
Daniel (December 2021). "Safe and
persistent growth-promoting
effects of
vosoritide in
children with achondroplasia: 2-year
results from an open-label, phase...
- 2010,
BioMarin also
announced a new
program for a
peptide therapeutic,
vosoritide (BMN-111), for the
treatment of achondroplasia. In 2012,
BioMarin acquired...
- a year
after originally rejecting that status. 15 November: The drug
Vosoritide, used to
treat achondroplasia, is
introduced in
Georgia after months of...
